Mei Pharma, Inc. (MEIP)

Trade MEIP now with
9/14/2020 9:22:35 PM Software Acquisition Group Inc. II Prices IPO Of 15 Mln Units At $10.00/unit
7/2/2020 7:12:37 AM Helsinn, MEI Pharma Discontinue Phase 3 Study With Pracinostat After Completing Interim Analysis
4/14/2020 2:10:31 PM MEI Pharma Appoints Cheryl Cohen To Its Board Of Directors
4/14/2020 7:03:20 AM MEI Pharma And Kyowa Kirin Announce Global License, Development And Commercialization Agreement For ME-401
3/31/2020 8:16:23 AM MEI Pharma Announces Fast Track Designation Granted By FDA For ME-401
12/17/2019 8:09:52 AM MEI Pharma Prices Underwritten Public Offering Of 28.1 Mln Shares At $1.60/shr
12/16/2019 4:05:36 PM MEI Pharma Announces Proposed Public Offering Of Common Stock
7/3/2019 8:01:54 AM MEI Pharma Appoints Tamar Howson To Board
12/1/2018 12:38:24 PM MEI Pharma Presents Preclinical Data Demonstrating Voruciclib Synergistically Induces Apoptosis With Venetoclax In AML
11/5/2018 8:05:08 AM MEI Pharma And Kyowa Hakko Kirin Announce License Deal To Develop And Commercialize ME-401 In Japan
10/11/2018 6:02:53 AM MEI Pharma And BeiGene Announce Clinical Collaboration To Evaluate ME-401 In Combination With Zanubrutinib
7/16/2018 8:04:46 AM MEI Pharma Promotes David Urso To COO
6/15/2018 8:05:38 AM MEI Pharma Presents Clinical Data On ME-401 At The European Hematology Association Congress
6/4/2018 8:10:58 AM MEI Pharma Presents Phase 1b Clinical Data For ME-401 In Patients With Indolent B-Cell Malignancies At ASCO